Maureen Murphy

3.8k total citations · 2 hit papers
6 papers, 3.0k citations indexed

About

Maureen Murphy is a scholar working on Oncology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Maureen Murphy has authored 6 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 1 paper in Pathology and Forensic Medicine and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Maureen Murphy's work include HER2/EGFR in Cancer Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer Treatment and Pharmacology (3 papers). Maureen Murphy is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer Treatment and Pharmacology (3 papers). Maureen Murphy collaborates with scholars based in United States. Maureen Murphy's co-authors include Stanford J. Stewart, Steven Shak, Dennis J. Slamon, Michael Burchmore, Debu Tripathy, Melody Cobleigh, Deborah Keefe, Mark Ashby, Clifford A. Hudis and Andrew D. Seidman and has published in prestigious journals such as Journal of Clinical Oncology and Blood.

In The Last Decade

Maureen Murphy

6 papers receiving 2.9k citations

Hit Papers

Efficacy and Safety of Trastuzumab as a Single Agent in F... 2002 2026 2010 2018 2002 2002 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
    2002 1.5k citations Charles L. Vogel, Melody Cobleigh et al. Journal of Clinical Oncology profile →
  2. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
    2002 1.1k citations Andrew D. Seidman, Clifford A. Hudis et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Murphy United States 5 2.3k 1.2k 781 697 491 6 3.0k
Stanford J. Stewart United States 9 2.5k 1.1× 1.5k 1.3× 778 1.0× 872 1.3× 534 1.1× 14 3.5k
Adam Knott United Kingdom 17 3.2k 1.4× 1.4k 1.2× 615 0.8× 843 1.2× 984 2.0× 33 4.2k
Marion Procter Belgium 13 2.3k 1.0× 849 0.7× 683 0.9× 345 0.5× 593 1.2× 34 2.8k
Dimitrios Zardavas Belgium 21 2.1k 0.9× 589 0.5× 232 0.3× 945 1.4× 854 1.7× 69 3.3k
Deborah Lindquist United States 10 2.5k 1.1× 812 0.7× 119 0.2× 655 0.9× 938 1.9× 22 3.0k
Steven Stein United States 11 3.0k 1.3× 1.0k 0.8× 112 0.1× 859 1.2× 1.2k 2.5× 21 3.7k
R. Mass United States 21 2.5k 1.1× 594 0.5× 101 0.1× 1.0k 1.5× 1.2k 2.4× 43 3.4k
Virginia McNally United Kingdom 18 2.5k 1.1× 866 0.7× 102 0.1× 582 0.8× 666 1.4× 38 3.0k
Elisabetta Munzone Italy 31 2.4k 1.0× 302 0.3× 230 0.3× 611 0.9× 765 1.6× 129 3.3k
Stephen D. Rubin United States 13 2.6k 1.2× 811 0.7× 103 0.1× 1.1k 1.6× 1.3k 2.7× 17 4.0k

Countries citing papers authored by Maureen Murphy

Since Specialization
Citations

This map shows the geographic impact of Maureen Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Murphy more than expected).

Fields of papers citing papers by Maureen Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Murphy. The network helps show where Maureen Murphy may publish in the future.

Co-authorship network of co-authors of Maureen Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Murphy. A scholar is included among the top collaborators of Maureen Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Murphy. Maureen Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Vogel, Charles L., Melody Cobleigh, Debu Tripathy, et al.. (2023). Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer. Journal of Clinical Oncology. 41(9). 1638–1645. 16 indexed citations
2.
Goy, André, Eric Hansen, Srikesh Arunajadai, et al.. (2016). Impact of Charlson Comorbidity Index (CCI) and Refining the MIPI Index in Mantle Cell Lymphoma (MCL). Blood. 128(22). 2973–2973. 1 indexed citations
3.
Tripathy, Debu, Dennis J. Slamon, Melody Cobleigh, et al.. (2004). Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression. Journal of Clinical Oncology. 22(6). 1063–1070. 221 indexed citations
4.
Vogel, Charles L., Melody Cobleigh, Debu Tripathy, et al.. (2002). Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer. Journal of Clinical Oncology. 20(3). 719–726. 1508 indexed citations breakdown →
5.
Osoba, David, Dennis J. Slamon, Michael Burchmore, & Maureen Murphy. (2002). Effects on Quality of Life of Combined Trastuzumab and Chemotherapy in Women With Metastatic Breast Cancer. Journal of Clinical Oncology. 20(14). 3106–3113. 111 indexed citations
6.
Seidman, Andrew D., Clifford A. Hudis, Mary Kathryn Pierri, et al.. (2002). Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience. Journal of Clinical Oncology. 20(5). 1215–1221. 1135 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanford J. Stewart Breakdown of academic impact, for papers by Adam Knott Breakdown of academic impact, for papers by Marion Procter Breakdown of academic impact, for papers by Dimitrios Zardavas Breakdown of academic impact, for papers by Deborah Lindquist Breakdown of academic impact, for papers by Steven Stein Breakdown of academic impact, for papers by R. Mass Breakdown of academic impact, for papers by Virginia McNally Breakdown of academic impact, for papers by Elisabetta Munzone Breakdown of academic impact, for papers by Stephen D. Rubin
Rankless by CCL
2026